Beruflich Dokumente
Kultur Dokumente
EFFICACY AND RETURN OF INVESTMENT OF THREE COMMERCIAL VACCINES SCHEMES AGAINST PORCINE CIRCOVIRUS TYPE 2 (PCV2) IN A MEXICAN HERD AFFECTED BY A SUBCLINICAL PORCINE CIRCOVIRUS ASSOCIATED DISEASE (PCVAD)
Rosales E., F. 1; De Grau, F. 2; Pia D., R. 1.
2 1 MSD-Salud Animal/Mxico. Merck-Animal Health/Canada.
jose.andres.francisco.rosales.espinosa@merck.com
Introduction
As a result of the severe PCVAD outbreaks during 2004-2007, commercial vaccines have appeared on the market and since then, PCV2 vaccination has become a core component of swine vaccination programs worldwide1,2. Several studies have shown that vaccination against PCV2 increases average daily gain (ADG) and decreases mortality rates3,4. Although PCV2 vaccines have specific label directions as required by regulatory authorities, many alternate, vaccination schemes have been adopted in the field to meet labor, management and disease control constraints5. The objective of our study was to evaluate three vaccination programs in a multi-site farm located in central Mexico. ADG, feed conversion (FC), mortality and number of pigs sold were measured and expected return on investment with each program was determined.
Results
Differences between the vaccine groups were observed for ADG, percentage of pigs market (regular and light weights, and culls), and mortality. Most importantly, there were significant differences in the feed cost (FPC)/kilo pig produced, FC and return of investment among the three vaccinated groups (Table 2).
References
Francisco et al., AASV Proc 2007; Fachinger et al., Vaccine 2008; 26:1488-99 Kristensen et al., Prev Vet Med 2011; 250258 Horlen et al., JAVMA, 232, 6, Mar, 2008 Cardinal & Jones, Proc Banff Pork Sem 2008 Deen et al., in Radostits: Herd Health. Food Anim Prod Med. 3 Ed 2001. Drs. Brad Thacker and Alex Eggen.
Acknowledgement
14
15